1.50432
LiChrosorb® RP-8 (5 µm) HPLC Columns
L x I.D. 125 mm x 4 mm, Hibar® RT HPLC Column
別名:
TM=["LiChrosorb"] C8 HPLC column
サイズを選択してください
この商品について
製品名
LiChrosorb® RP-8 (5 µm) Hibar® RT 125-4, suitable for HPLC
material
stainless steel column
Quality Segment
agency
suitable for USP L7
product line
LiChrosorb®
feature
endcapped: no
analyte functional class(es)
antibiotics, fat soluble vitamins, lipids, nutraceuticals and antioxidants, oils, pigments
analyte chemical class(es)
PCBs (aroclor identification), PFAS, aflatoxins, alcohols and aldehyde, alkaloids, amino acids, cannabinoids as tms derivatives, carotenoids, coloring compounds, essential oils, esters, fatty acids, flavonoids, ketones, metabolized steroids, nitrosamines, nucleosides, oligonucleotides, peptides, pesticides, phenols, phospholipids, phthalate esters, preservatives, proteins, steroids (cholesteryl esters), sulfonamides
parameter
400 bar pressure, 60 °C max. temp.
technique(s)
HPLC: suitable, mass spectrometry (MS): suitable (Low)
column L × I.D.
12.5 cm × 4 mm
matrix
fully porous particle
matrix active group
C8 (RP8), C8 bonding phase
particle size
5 μm
pore size
100 Å pore size
operating pH range
2-7.5
separation technique
reversed phase, supercritical fluid (SFC)
storage temp.
no temp limit
General description
Application
- Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography.: This study by Egger et al. focuses on the HPLC determination of various forms of amphotericin B in plasma, utilizing LiChrosorb® RP-8 as the stationary phase. This method ensures accurate monitoring of these antifungal agents in clinical settings (Egger et al., 2001).
- Determination of peptide hydrophobicity parameters by reversed-phase high-performance liquid chromatography.: This research by Rothemund et al. used LiChrosorb® RP-8 to determine the hydrophobicity of various peptides, providing valuable insights for peptide characterization in biochemical research (Rothemund et al., 1994).
- HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patients.: Beijnen et al. employed LiChrosorb® RP-8 in an HPLC method to quantify doxorubicin and its metabolites in plasma, offering a robust tool for therapeutic drug monitoring in AIDS patients (Beijnen et al., 1991).
Analysis Note
Theoretical Plates (N/m) (Toluene): ≥ 55000
Symmetry (Toluene): 0.8 - 1.4
Capacity factor (Toluene): 0.5 - 1.5
Legal Information
Still not finding the right product?
Explore all of our products under LiChrosorb® RP-8 (5 µm) Hibar® RT 125-4